glucosamine 6-phosphate | 45170-71-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: glucosamine 6-phosphate
• 英文别名: 2-amino-O⁶-phosphono-2-deoxy-D-galactose；2-Amino-O⁶-phosphono-2-desoxy-D-galactose；D-Galactosamin-6-phosphat；O⁶-Phosphono-D-galactosamin；[(2R,3R,4R,5R)-5-amino-2,3,4-trihydroxy-6-oxohexyl] dihydrogen phosphate
• CAS: 45170-71-6
• 化学式: C₆H₁₄NO₈P
• 分子量: 259.153
• InChiKey: AEJSSXDYDSUOOZ-KCDKBNATSA-N

物化性质

• 沸点：
  652.2±65.0 °C(Predicted)
• 密度：
  1.749±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -7.1
• 重原子数：
  16
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  171
• 氢给体数：
  6
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  glucosamine 6-phosphate 、 乙酸酐 在 碳酸氢钠 作用下， 生成 2-acetylamino-O⁶-phosphono-2-deoxy-D-galactose
  参考文献：
  名称：

  Distler et al., Journal of Biological Chemistry, 1958, vol. 230, p. 497,503,504

  摘要：

  DOI：
• 作为产物：
  描述：

  2-氨基-2-脱氧-D-半乳糖盐酸盐 在 PPA 作用下， 生成 glucosamine 6-phosphate
  参考文献：
  名称：

  Distler et al., Journal of Biological Chemistry, 1958, vol. 230, p. 497,503,504

  摘要：

  DOI：

文献信息

• GLMS RIBOSWITCHES, STRUCTURE-BASED COMPOUND DESIGN WITH GLMS RIBOSWITCHES, AND METHODS AND COMPOSITIONS FOR USE OF AND WITH GLMS RIBOSWITCHES
  申请人：Breaker Ronald R.

  公开号：US20100324123A1

  公开（公告）日：2010-12-23

  The glmS riboswitch is a target for antibiotics and other small molecule therapies. Compounds can be used to stimulate, active, inhibit and/or inactivate the glmS riboswitch. The atomic structures of the glmS riboswitch can be used to design new compounds to stimulate, active, inhibit and/or inactivate riboswitches.

  glmS核酸开关是抗生素和其他小分子治疗的靶点。化合物可以用于刺激、激活、抑制和/或失活glmS核酸开关。glmS核酸开关的原子结构可用于设计新的化合物，以刺激、激活、抑制和/或失活核酸开关。
• Oligonucleotide compounds, their production and use
  申请人：TAKEDA CHEMICAL INDUSTRIES, LTD.

  公开号：EP0653438A2

  公开（公告）日：1995-05-17

  An oligonucleotide compound or a salt thereof, which has a nucleotide sequence represented by formula (I): wherein W represents hydrogen or a protective group; B1, B2 and B3 each represent nucleic acid residues, wherein each B2 may be the same or different when n is 2 or more; X1, X2 and X3 each represent OH, SH, C1-5 alkyl, C1 -5 alkoxy, C1 -5 monoalkylamino or an aromatic ring group which may be substituted or unsubstituted, wherein each X3 may be the same or different when n is 2 or more; R1, R2 and R3 each represent hydrogen, OH, halogen, C1 -5 alkoxy or C1 -5 alkoxyalkyloxy, wherein each R2 may be the same or different when n is 2 or more; and n represents an integer from 1 to 98 is disclosed. The oligonucleotides (I) of the present invention or the salts thereof can (1) inhibit expression of genes associated with the development of malignant tumors in malignant tumor cells, (2) inhibit expression of viral genes derived from viruses, (3) inhibit expression of genes producing proteins which contribute to the development of inflammations, (4) control expression of drug-resistant genes which cause complications in chemotherapy of malignant tumors, and (5) inhibit production of cell growth factors related to reangiostenosis after PCTA (percutaneous transluminal coronary angioplasty) by complementation to DNAs or mRNAs of genes inducing various diseases. They can be therefore used as antitumor agents, antiviral agents, antiinflammatory agents and drugs for controlling expression of specific genes such as resistance genes. These oligonucleotides can also be used as probes. Further, these oligonucleotides can be used in novel drug screening assays.

  一种寡核苷酸化合物或其盐，其核苷酸序列由式 (I) 表示： 其中 W 代表氢或保护基团；B1、B2 和 B3 各自代表核酸残基，其中当 n 为 2 或更多时，每个 B2 可相同或不同；X1、X2 和 X3 各自代表 OH、SH、C1-5 烷基、C1-5 烷氧基、C1-5 单烷基氨基或可被取代或未被取代的芳环基团，其中当 n 为 2 或更多时，每个 X3 可相同或不同；R1、R2 和 R3 各自代表氢、OH、卤素、C1 -5 烷氧基或 C1 -5 烷氧基，其中当 n 为 2 或更多时，每个 R2 可以相同或不同；n 代表 1 至 98 的整数。 本发明的寡核苷酸（I）或其盐类可以：(1) 抑制恶性肿瘤细胞中与恶性肿瘤发展有关的基因的表达；(2) 抑制来自病毒的病毒基因的表达；(3) 抑制产生有助于炎症发展的蛋白质的基因的表达、(4) 控制导致恶性肿瘤化疗并发症的耐药基因的表达，以及 (5) 通过与诱发各种疾病的基因的 DNA 或 mRNA 互补，抑制与经皮冠状动脉成形术（PCTA）后再狭窄有关的细胞生长因子的产生。因此，这些寡核苷酸可用作抗肿瘤药、抗病毒药、消炎药和控制特定基因（如抗性基因）表达的药物。这些寡核苷酸还可用作探针。此外，这些寡核苷酸还可用于新型药物筛选试验。
• Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
  申请人：Ceres Incorporated

  公开号：EP1033405A2

  公开（公告）日：2000-09-06

  The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3' termination sequence, and are also useful in controlling the behavior of a gene in the chromosome, in controlling the expression of a gene or as tools for genetic mapping, recognizing or isolating identical or related DNA fragments, or identification of a particular individual organism, or for clustering of a group of organisms with a common trait. 0Arabidopsis DNA is used in the present experiment, but the procedure is a general one.

  本发明提供了构成植物基因组片段的 DNA 分子及其编码的多肽。这些 DNA 分子可作为启动子或蛋白质编码序列或 UTR 或 3'终止序列，用于指定细胞中的基因产物，也可用于控制染色体中基因的行为，控制基因的表达，或作为基因绘图、识别或分离相同或相关 DNA 片段、或识别特定生物个体、或对具有共同性状的生物群体进行聚类的工具。 本实验中使用的是拟南芥 DNA，但这是一个通用程序。
• DNA Sequences
  申请人：Ceres Incorporated

  公开号：EP1887081A2

  公开（公告）日：2008-02-13

  The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3' termination sequence, and are also useful in controlling the behavior of a gene in the chromosome, in controlling the expression of a gene or as tools for genetic mapping, recognizing or isolating identical or related DNA fragments, or identification of a particular individual organism, or for clustering of a group of organisms with a common trait.

  本发明提供了构成植物基因组片段的 DNA 分子及其编码的多肽。这些 DNA 分子可作为启动子或蛋白质编码序列或 UTR 或 3'终止序列，用于指定细胞中的基因产物，也可用于控制染色体中基因的行为，控制基因的表达，或作为基因绘图、识别或分离相同或相关 DNA 片段、或识别特定生物个体或具有共同性状的生物群体的工具。
• HUMAN CARBOHYDRATE METABOLISM ENZYMES
  申请人：——

  公开号：US20020061301A1

  公开（公告）日：2002-05-23

  The invention provides human carbohydrate metabolism enzymes (CARM) and polynucleotides which identify and encode CARM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of CARM.

  本发明提供了人类碳水化合物代谢酶（CARM）以及识别和编码 CARM 的多核苷酸。本发明还提供了表达载体、宿主细胞、抗体、激动剂和拮抗剂。本发明还提供了诊断、治疗或预防与 CARM 表达有关的疾病的方法。